article thumbnail

Doctoral Capstone Presentations

Blog: Ask a Student Pharmacist

Doctoral Capstone Presentations pbhamidi Thu, 08/22/2024 - 13:28 Blending Scientific Knowledge of the Human Body, Mind, Emotions and Spirit Doctoral Capstone Presentations Below are links to the brief presentations of doctoral capstone projects. Interested in working with an OTD capstone student or exploring the possibility?

article thumbnail

Quality Essentials Review: Advancing Medication Therapy Management Quality Measurement

PQA

Cooke, Research Associate Professor at the University of Maryland School of Pharmacy, Aaron Larson, VP of Health Plan Quality Analytics at UnitedHealth Group and Anita Pothen Skaria, Vice President of Quality and Process Improvement with Centene Corporation. Develop new performance measures for MTM quality.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.

article thumbnail

Understanding Large Molecule Drug Development: From Biologics to Market

Impact Pharmaceutical Services

Both processes are evolving to enhance product development and output. Upstream processing advancements encompass fed-batch processes , improved cell culture media, advanced feeding strategies, and tailored bioreactor control.

article thumbnail

Avoid CMC Challenges by Thinking Slow, Not Fast-Discussions at USP’s Workshop

The FDA Law Blog

The workshop included presentations by USP on its available standards for advanced therapies, FDA/CBER on CMC challenges for CART cell therapies, and industry approaches to potency testing during CART development, and using Analytical Quality by Design (AQbD) principles in potency assay development. Release testing alone is not sufficient.

FDA 57
article thumbnail

Personalised culture media solutions support timely biopharmaceutical manufacturing

European Pharmaceutical Review

They need to resolve any issues that affect cell performance and quality, whether it is media optimisation or process improvement. Our R&D team is happy to present custom media development and manufacturing options for our clients to consider, to meet these challenges.

article thumbnail

Drug development trends: insight from Thermo Fisher’s Anil Kane

European Pharmaceutical Review

For example, in selecting the best technology, we can obtain and use data-based analytics to design scale of tech transfer, to make scientific, data-based process improvements, and to bring efficiencies in process. Also, we can expect to see the utilisation of digital technologies for predictive modelling.

Dosage 98